Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Navan Inc. Class A Common Stock (NAVN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Navan Inc. Class A Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.4 (market cap $4.59B), while Navan Inc. Class A Common Stock trades at $23.16 (market cap $6.01B). The key difference: Navan Inc. Class A Common Stock is the larger of the two by market cap, and Navan Inc. Class A Common Stock is more actively traded (2,990,425 versus 2,103,937). Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Navan Inc. Class A Common Stock for 0 Days on average.
| DFTX | NAVN | |
|---|---|---|
Market Cap | $4.59B | $6.01B |
Volume | 2,103,937 | 2,990,425 |
Sector | Health | Technology |
52-Week High | $48.45 | $30.58 |
52-Week Low | $10.68 | $8.51 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $5.36B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Navan Inc. Class A Common Stock
Navan provides an AI-powered platform for business travel, payments, and expense management. Its tools support trip booking, policy controls, payment processing, expense reconciliation, and reporting.
Read more on NAVN →
